Massive 10,000-Patient study tracks stroke Drug's Real-World performance
NCT ID NCT07271342
Summary
This study is tracking 10,000 stroke patients across China who receive the clot-busting drug tenecteplase as part of their regular hospital care. Researchers want to see how well the treatment works and how safe it is in everyday medical practice, not just in controlled trials. The goal is to improve stroke treatment quality nationwide by understanding real patient outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
RECRUITINGBeijing, 100070, China
Conditions
Explore the condition pages connected to this study.